DriveWealth Power Saver ETF (EERN)
- Previous Close
3.4150 - Open
3.6900 - Bid 3.3500 x 3000
- Ask --
- Day's Range
3.3101 - 3.5100 - 52 Week Range
3.3101 - 3.5100 - Volume
4,345 - Avg. Volume
0 - Net Assets 33.58k
- NAV 3.35
- PE Ratio (TTM) --
- Yield 546.35%
- YTD Daily Total Return -7.63%
- Beta (5Y Monthly) 0.00
- Expense Ratio (net) 2.14%
The fund invests generally in a diversified portfolio of securities of unaffiliated exchange-traded funds ("ETFs" or "underlying funds"). Underlying funds will invest in income producing securities, including money market funds, corporate securities and municipal debt of any rating. Under normal market conditions, it will invest primarily in underlying funds focusing on investment grade and high yield corporate bonds; asset-backed and mortgage-back securities; emerging markets securities; United States government securities; sovereign debt; and preferred securities.
RBB Funds
Fund Family
Multisector Bond
Fund Category
33.58k
Net Assets
2021-07-26
Inception Date
Performance Overview: EERN
Trailing returns as of 9/2/2022. Category is Multisector Bond.
Holdings: EERN
Top 10 Holdings (830.53% of Total Assets)
Sector Weightings
Related ETF News
Research Reports: EERN
Analyst Report: AutoNation, Inc.
AutoNation is the largest automotive dealer in the United States, with 2021 revenue of $25.8 billion and about 250 dealerships at nearly 350 locations, plus 57 collision centers. The firm also has 11 AutoNation USA used-vehicle stores, four auction sites, and three parts distributors all across 17 states primarily in Sunbelt metropolitan areas. New-vehicle sales account for about half of revenue; the company also sells used vehicles, parts, and repair services as well as auto financing. The company (formerly Republic Industries) spun off its waste management unit (Republic Services) in 1999 and its car rental businesses (ANC Rental) in 2000. Wayne Huizenga founded the company in the 1990s to bring the rollup acquisition strategy to auto retailing, which has proved to be a smart move.
RatingPrice TargetAnalyst Report: CarMax Inc
CarMax Inc. is primarily a retailer of used vehicles in the U.S. Established in 1993, the company operates over 200 used car stores. CarMax has two segments: CarMax Sales Operations and CarMax Auto Finance (CAF). The Sales Operations segment sells used vehicles, purchases used vehicles, arranges financing options, and sells related products and services. CAF provides auto financing to CarMax customers, services the loans it originates, provides billing statements, collects payments, and coordinates the repossession of vehicles as needed. The company also receives income from expanded protection plans and service revenue. The company reported FY22 net revenue of $31.9 billion. Headquartered in Richmond, Virginia, it has approximately 27,000 employees.
RatingPrice TargetAnalyst Report: CarMax, Inc.
CarMax sells, finances, and services used and new cars through a chain of over 220 used retail stores. It was formed in 1993 as a unit of Circuit City and spun off into an independent company in late 2002. Used-vehicle sales account for about 83% of revenue and wholesale about 14%, with the remaining portion composed of extended service plans and repair. In fiscal 2021, the company retailed and wholesaled 751,862 and 426,268 used vehicles, respectively. CarMax is the largest used-vehicle retailer in the U.S. but still estimates that it has only about 3.5% U.S. market share of vehicles 0-10 years old. It seeks over 5% share by the end of calendar 2025. CarMax is based in Richmond, Virginia.
RatingPrice TargetAnalyst Report: Centene Corporation
Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.
RatingPrice Target